欢迎访问《中国临床药理学与治疗学》杂志官方网站,今天是 分享到:

中国临床药理学与治疗学 ›› 2023, Vol. 28 ›› Issue (10): 1195-1200.doi: 10.12092/j.issn.1009-2501.2023.10.014

• 综述与讲座 • 上一篇    下一篇

瑞马唑仑的临床研究进展

忻钰棋1,曹  亚2,王玉龙2   

  1. 1安徽芜湖皖南医学院麻醉学院;
    2安徽芜湖皖南医学院弋矶山医院麻醉科,芜湖  241000,安徽

  • 收稿日期:2023-03-07 修回日期:2023-06-11 出版日期:2023-10-26 发布日期:2023-10-26
  • 通讯作者: 曹亚,女,本科,副主任医师,研究方向:危急重症麻醉管理,急救与复苏,医学模拟教育。 E-mail:cyyjslove@126.com
  • 作者简介:忻钰棋,女,研究方向:临床麻醉。 E-mail:1004463358@qq.com
  • 基金资助:
    2022年皖南医学院中青年科研基金项目(WK2022F03)

Progress in clinical research on remazolam

XIN Yuqi1, CAO Ya2,  WANG Yulong2   

  1. 1School of Anesthesiology, Wannan Medical College, Wuhu 241000, Anhui, China; 2Department of Anesthesiology, Yijishan Hospital, Wannan Medical College, Wuhu 241000, Anhui, China
  • Received:2023-03-07 Revised:2023-06-11 Online:2023-10-26 Published:2023-10-26

摘要: 苯二氮卓类药物是麻醉领域最常用的药物之一。瑞马唑仑是一种新开发的超短效苯二氮卓类药,它具有起效快、恢复快、安全性高等特点,并且低血压、呼吸抑制等副作用少。本综述旨在概述瑞马唑仑的药代动力学、临床药理学作用机制和临床应用的研究进展。

关键词: 瑞马唑仑, 超短效苯二氮卓类药, 镇静剂

Abstract: Benzodiazepines are among the most commonly used drugs in the field of anesthesia. Remazolam is a newly developed ultra-short-acting benzodiazepine, which has the characteristics of rapid onset, rapid recovery, high safety, and less side effects such as hypotension and respiratory depression. The aim of this review is to summarize the progress of pharmacokinetics, clinical pharmacology mechanism of action and clinical application of remazolam.

Key words: remimazolam, ultra short acting benzodiazepine, sedative

中图分类号: